Cargando…

Genetic polymorphisms, efficiency and toxicity of cancer chemotherapy

Detalles Bibliográficos
Autores principales:	Tecza, Karolina, Pamula-Pilat, Jolanta, Kolosza, Zofia, Radlak, Natalia, Grzybowska, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565104/ http://dx.doi.org/10.1186/1897-4287-13-S1-A5

Ejemplares similares

Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Copper transport system and response to ovarian cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015)

Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2016)

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018)

Spectrum of tumors in the families with Hereditary Breast Ovarian Cancer syndrome carrying germline mutations in BRCA1 and 2 genes
por: Budryk, M, et al.
Publicado: (2012)

Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients
por: Pamuła-Piłat, Jolanta, et al.
Publicado: (2020)

High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk
por: Wagner, Kerstin, et al.
Publicado: (2007)

Clinicopathological characteristics of breast cancer patients with NOD2 mutation according to age
por: Huszno, Joanna, et al.
Publicado: (2020)

Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factors
por: Huszno, Joanna, et al.
Publicado: (2022)

The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation
por: Huszno, Joanna, et al.
Publicado: (2015)

Gene Expression Analysis in Ovarian Cancer – Faults and Hints from DNA Microarray Study
por: Lisowska, Katarzyna Marta, et al.
Publicado: (2014)

Prevalence of the most frequent BRCA1 mutations in Polish population
por: Brozek, Izabela, et al.
Publicado: (2011)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015
por: Thompson, Ella R., et al.
Publicado: (2017)

Selenium and cancer – what have we learned from epidemiology and molecular epidemiology studies?
por: Jablonska, Ewa, et al.
Publicado: (2015)

Functional Impact of Sequence Alterations Found in BRCA1 Promoter/5'UTR Region in Breast/Ovarian Cancer Families from Upper Silesia, Poland
por: Pamuła, Jolanta, et al.
Publicado: (2006)

Polymorphisms and genetic susceptibility of type 1 diabetes mellitus and celiac disease
por: Bastos, Marília Dornelles, et al.
Publicado: (2015)

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Methotrexate (MTX) inhibition of cytokine production: relationship with clinical outcome and genetic polymorphisms
por: Sabina, P, et al.
Publicado: (2003)

Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy
por: Chenevix-Trench, Georgia, et al.
Publicado: (2012)

Association of CYP2D6*4 genetic polymorphism on the metabolism of Donepezil with Alzheimer's disease in Indian population
por: Subbiah, Vivekanandhan, et al.
Publicado: (2010)

Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients
por: Jensen, MA, et al.
Publicado: (2012)

FTO polymorphism (RS9939609) and BED in patients with morbid obesity for evaluation towards bariatric surgery
por: Horvath, Jaqueline Driemeyer C, et al.
Publicado: (2015)

High-dose chemotherapy in breast cancer: Dutch randomized studies
por: Rodenhuis, S, et al.
Publicado: (2001)

Developmental toxicity of pharmaceuticals in lower vertebrates
por: Berg, Cecilia, et al.
Publicado: (2012)

Mutations and polymorphisms of genes moderate increase in gastric cancer risk
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

Predictiting valproate toxicity in patients with mitochondrial disorders
por: Remenyi, Viktoria, et al.
Publicado: (2014)

The pulmonary and haematological toxicity of inhaled aerosolised prostacyclin
por: van Heerden, PV, et al.
Publicado: (1997)

Genetic polymorphisms leading to altered T-cell and dendritic cell function cooperate to produce expansion of proinflammatory T-cell subsets in NZB c1 congenic mice
por: Talaei, N, et al.
Publicado: (2012)

Toxicity of ascaridole from Chenopodium ambrosioides in mammalian mitochondria
por: Gille, Lars, et al.
Publicado: (2010)

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience
por: Krajewska, Jolanta, et al.
Publicado: (2013)

Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR) imaging
por: Turnbull, LW, et al.
Publicado: (2002)

Subclinical hypothyroidism in population of aging Polish women and men over 65yrs old and cardiovascular risk factor, endogenous vitamin D levels and its gene receptor polymorphisms – PolSenior Study
por: Milewicz, Andrzej, et al.
Publicado: (2013)

Implanted markers prior to neoadjuvant chemotherapy: preliminary report
por: Allan for the Dartford Breast Care Team, DM
Publicado: (2000)

Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer
por: Beesley, Jonathan, et al.
Publicado: (2012)

CNP attenuates renal toxicity induced by cisplatin in murine kidney
por: Kimura, Toru, et al.
Publicado: (2015)

Clinical genetics in cancer prevention
por: Elsakov , Pavel
Publicado: (2012)

A single nucleotide polymorphism on the IL-10 locus defines an expression polymorphism and a possible risk factor to develop RA
por: Lard, LR, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_f72e8grapajp5t1162h6emn4de